Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 1 - Drugs for disorders of the alimentary tract or the digestive system
Patents for A61P 1 - Drugs for disorders of the alimentary tract or the digestive system (125,798)
05/2012
05/29/2012CA2554730C Oral care compositions comprising increased bioavailable levels of quaternary ammonium antimicrobials
05/29/2012CA2529561C Methanesulfonic acid salt of pyrazolopyrimidine compound, crystal thereof, and process for producing the same
05/29/2012CA2502219C A process for producing an amorphous isomer of lansoprazole
05/29/2012CA2482499C Aerosol containing a particulate active substance
05/29/2012CA2481036C (3z)-(3-(3-hydro-isobenzofuran-1-ylidene)-1,3-dihydro-2h-indol-2-ones as kinase inhibitors
05/29/2012CA2458611C Aminobenzophenones as interleukin 1-beta and tumour necrosis factor-alpha inhibitors
05/29/2012CA2417389C Therapeutic polyesters and polyamides
05/29/2012CA2389429C Compositions and methods for counteracting effects of reactive oxygen species and free radicals
05/29/2012CA2338005C Peptide antagonists of zonulin and methods for use of the same
05/24/2012WO2012068529A2 Cannabinoid receptor antagonists-inverse agonists useful for treating metabolic disorders, including obesity and diabetes
05/24/2012WO2012068209A2 Bisthiazole inhibitors of pro-matrix metalloproteinase activation
05/24/2012WO2012068081A1 Intraesophageal administration of targeted nitroxide agents for protection against ionizing irradiation-induced esophagatis
05/24/2012WO2012067614A1 Periodontitis treatment
05/24/2012WO2012067437A2 Composition for increasing liver volume for the purpose of liver resection
05/24/2012WO2012067111A1 PKC-ε ACTIVATOR
05/24/2012WO2012065362A1 Myomegalin variant 8 and uses thereof
05/24/2012WO2012065286A1 Composition of dna vaccine for preventing and treating hepatitis b
05/24/2012WO2012023008A3 Polysaccharide conjugation with detoxified e. coli heat labile enterotoxin (lt) used as vaccine
05/24/2012WO2012006497A3 Mu opioid receptor agonist analogs of the endomorphins
05/24/2012WO2011163539A3 nAChRα7 AGONISTS AND nAChRα7 ANTAGONISTS FOR TREATING ULCERATIVE COLITIS (UC) AND CROHN'S DISEASE (CD)
05/24/2012US20120130300 Therapeutic Methods Using Controlled Delivery Devices Having Zero Order Kinetics
05/24/2012US20120129935 Nutrition with lipids and non-digestible saccharides
05/24/2012US20120129930 Ketone compounds and compositions for cholesterol management and related uses
05/24/2012US20120129926 Novel calcium sensing receptor modulating compounds and pharmaceutical use thereof
05/24/2012US20120129924 Uses of sesquiterpene derivatives
05/24/2012US20120129906 Modulators of s1p receptors
05/24/2012US20120129897 Bis heteroaryl inhibitors of pro-matrix metalloproteinase activation
05/24/2012US20120129892 Novel pharmaceutically acceptable salts of 4-(1h-imidazol-4-ylmethyl)pyridine and their therapeutical uses
05/24/2012US20120129891 Sulfone derivative
05/24/2012US20120129886 Metalloenzyme inhibitor compounds
05/24/2012US20120129873 Inhibitors of bruton's tyrosine kinase
05/24/2012US20120129872 Fused heteroaryl inhibitors of pro-matrix metalloproteinase activation
05/24/2012US20120129864 Substituted 1-alkylcinnolin-4(1h)-one derivatives, preparation thereof and therapeutic application of same
05/24/2012US20120129862 Prokineticin 1 receptor antagonists
05/24/2012US20120129858 Compounds, compositions and methods comprising pyridazine sulfonamide derivatives
05/24/2012US20120129856 Compounds, compositions and methods useful for cholesterol mobilisation
05/24/2012US20120129851 Substituted Quinazoline and Pyrido-Pyrimidine Derivatives
05/24/2012US20120129843 Pyridyl-thiazolyl inhibitors of pro-matrix metalloproteinase activation
05/24/2012US20120129842 Bisthiazole inhibitors of pro-matrix metalloproteinase activation
05/24/2012US20120129833 Cyclic ketoenols for therapy
05/24/2012US20120129832 Amide derivative
05/24/2012US20120129830 7-aza-spiro[3.5]nonane-7-carboxylate derivatives, preparation thereof and therapeutic use thereof
05/24/2012US20120129829 Novel indole modulators of s1p receptors
05/24/2012US20120129828 S1p1 receptor agonists and use thereof
05/24/2012US20120129820 New pharmaceutical compositions for treatment of respiratory and gastrointestinal disorders
05/24/2012US20120129816 Aryl sulfonamide amine compounds and their use as 5-ht6 ligands
05/24/2012US20120129814 Novel phosphonic acids as s1p receptor modulators
05/24/2012US20120129813 Novel compounds as receptor modulators with therapeutic utility
05/24/2012US20120129811 Tricyclic inhibitors of pro-matrix metalloproteinase activation
05/24/2012US20120129807 Methods of treatment, improvement and prevention using haloaryl substituted aminopurines
05/24/2012US20120129805 Barley and uses thereof
05/24/2012US20120129778 Ligand that bind tgf-beta receptor rii
05/24/2012US20120129766 Methods of treating fgf21-associated disorders
05/24/2012US20120129762 Motilin-like peptide compound having transmucosal absorbability imparted thereto
05/24/2012US20120128807 Composition for preventing or treating irritable bowel syndrome
05/24/2012US20120128797 Method for treatment of constipation-predominant irritable bowel syndrome
05/24/2012US20120128795 Colorless, non-fuming, hazardless and stable aqua-regia, its preparation method and use in treating medical disorders
05/24/2012US20120128778 Compositions and methods for once-daily administration of a trilayer osmotic tablet
05/24/2012US20120128771 Timed, pulsatile release systems
05/24/2012US20120128768 Active substance combination comprising a compound with npy receptor affinity and a compound with 5-ht6 receptor affinity
05/24/2012US20120128722 Novel Monensin Derivatives for the Treatment and Prevention of Protozoal Infections
05/24/2012US20120128690 Methods for determining agents that treat or prevent obesity and/or obesity related diseases and methods for treatment therewith
05/24/2012US20120128689 Anti-il-23 immunoglobulins
05/24/2012US20120128675 Anti-fgf19 antibodies and methods using same
05/24/2012US20120128657 Synthetic macrocyclic compounds and methods for treating cancer
05/24/2012US20120128645 Prophylactic, ameliorating or therapeutic agent for oral diseases
05/24/2012US20120128636 Gingiva Derived Stem Cell And Its Application In Immunodulation And Reconstruction
05/24/2012US20120128634 Use of collinsella aerofaciens for reducing bloating
05/24/2012US20120128633 Use of collinsella aerofaciens for reducing bloating
05/24/2012US20120128631 Compositions and methods for kinase-mediated cytoprotection and enhanced cellular engraftment and persistence
05/24/2012US20120128629 Method of labelling interferons with peg
05/24/2012US20120128628 COMBINATION OF A NUCLEOSIDE POLYMERASE INHIBITOR WITH A MACROCYCLIC PROTEASE INHIBITOR AND USE THEREOF IN THE TREATMENT OF HEPATITIS C, LIVER FIBROSIS AND IMPAIRED LIVER FUNCTION (as amended)
05/24/2012US20120125325 The use of amlexanox in the therapy of neutrophil-driven diseases
05/24/2012CA2818130A1 Orally administered pharmaceutical composition and preparation method thereof, for the prevention and treatment of irritable bowel syndrome, comprising an intestinal motility modifier and a-d-galactosidase
05/24/2012CA2818129A1 Orally administered pharmaceutical composition for the treatment of irritable bowel syndrome, comprising an intestinal motility modifier, an agent that prevents gas retention, and digestive enzymes, and preparation method thereof
05/24/2012CA2817982A1 Controlled release mucoadhesive systems
05/23/2012EP2455467A1 Double-stranded oligonucleotides
05/23/2012EP2455379A1 Crystals of pyrroloquinolinequinone sodium salts
05/23/2012EP2455363A1 Method for manufacturing spilanthol and intermediate manufacturing product therefor
05/23/2012EP2455096A1 Oxidized protein hydrolase activity enhancer
05/23/2012EP2455095A1 Prophylactic, ameliorating or therapeutic agent for oral diseases
05/23/2012EP2455094A1 Non-replicating probiotic micro-organisms protect children against gastrointestinal infections
05/23/2012EP2455081A1 S1P1 receptor agonists for use in the treatment of crohn's disease
05/23/2012EP2455077A1 Prophylactic and/or therapeutic agent for dysmenorrhea
05/23/2012EP2454265A2 Deuterated 2, 4-pyrimidinediamine compounds and prodrugs thereof and their uses
05/23/2012EP2453922A1 Antibacterial oral composition
05/23/2012EP2453889A1 Use of proanthocyanidins for production of an antiadhesive preparation
05/23/2012EP2453882A1 Methods of increasing liver proliferation
05/23/2012EP2453757A1 Method of processing cereal grain with lactic acid for use in ruminant feed
05/23/2012EP2124946B1 The use of n-methyl pyridinium derivatives for hepatoprotection
05/23/2012EP2046740B1 Compounds having crth2 antagonist activity
05/23/2012EP1932522B1 Therapeutic agent for liver disease containing 2-amino-1,3-propanediol derivative as active ingredient
05/23/2012EP1789067B1 Use of growth hormone secretagogues for stimulating the motility of the gastrointestinal system
05/23/2012EP1325014B1 Gamma-hydroxybutyrate compositions containing carbohydrate carriers
05/23/2012CN202223586U Traditional Chinese medicine pulp for treating combined gallbladder channel tissue and kidney channel tissue diseases and package thereof
05/23/2012CN202223585U Traditional Chinese medicine pulp for treating combined gallbladder channel tissue and liver channel tissue diseases and package thereof
05/23/2012CN202223584U Traditional Chinese medicine slurry for treating diseases of tissues of both gallbladder channel and heart channel and packaging thereof
05/23/2012CN202223583U Traditional Chinese medicine slurry for treating diseases of tissues of liver channel and packaging thereof
05/23/2012CN1961897B Method for verifying pomegranate rind extract
05/23/2012CN1876038B A Chinese medicinal composition for treating stomach and abdomen pain and preparation method thereof
1 ... 223 224 225 226 227 228 229 230 231 232 233 234 235 236 237 238 239 240 241 242 243 ... 1258